Research on GLP-1 initially focused on anti-diabetes, but the recent discovery of its anti-obesity effect shifted the focus of the research, which led us to the idea that LCM might also have an anti-obesity effect and prompted this study. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.